1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Penile Carcinoma: new trials by email Literature Review of Penile Carcinoma trials Research Report on Penile Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma Dostarlimab, Niraparib - Penile Carcinoma | Phase 2 | Recruiting | H. Lee Moffitt Cancer Center and Research Institute | 25 | 2022-12-28 | 2025-12-04 |
| Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer Pembrolizumab, Standard of care therapy - Penile Carcinoma | Phase 2 | Completed | Latin American Cooperative Oncology Group | 37 | 2020-06-15 | 2024-03-13 |
Penile Neoplasms (2)
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Penile Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
dostarlimab (1) · niraparib (1) · pembrolizumab (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · Latin American Cooperative Oncology Group (1)
Brazil (1) · United States (1)
Fernando Cotait Maluf (1) · Juskaran Chadha, DO (1)